http://www.contractpharma.com Tue, 21 May 2013 19:20:11 -0500 FeedCreator 1.7.2 http://www.contractpharma.com/contents/view_experts-opinion/2012-07-13/certification-helps-biocompatibility-labs-provide-service-value-and-productivity/ NRCM can increase knowledge and confidence and become part of the culture Fri, 13 Jul 2012 00:00:00 -0500 http://www.contractpharma.com/contents/view_experts-opinion/2012-07-13/certification-helps-biocompatibility-labs-provide-service-value-and-productivity/ http://www.contractpharma.com/contents/view_experts-opinion/2012-07-10/7-tips-for-selecting-a-cmo/ What to look for, and why Tue, 10 Jul 2012 00:00:00 -0500 http://www.contractpharma.com/contents/view_experts-opinion/2012-07-10/7-tips-for-selecting-a-cmo/ http://www.contractpharma.com/contents/view_experts-opinion/2012-05-30/how-vcs-are-impacting-the-pharma-sector/ Big Pharma and venture capital reshape the CMO/CRO markets Wed, 30 May 2012 00:00:00 -0500 http://www.contractpharma.com/contents/view_experts-opinion/2012-05-30/how-vcs-are-impacting-the-pharma-sector/ http://www.contractpharma.com/contents/view_experts-opinion/2012-05-15/dsm-biomedical-a-case-study-for-developing-a-new-business/ What does the Kensey Nash deal say about DSM's growth strategy? Tue, 15 May 2012 00:00:00 -0500 http://www.contractpharma.com/contents/view_experts-opinion/2012-05-15/dsm-biomedical-a-case-study-for-developing-a-new-business/ http://www.contractpharma.com/contents/view_experts-opinion/2012-03-21/ma-in-big-pharma/ Holy Grail or Buying Time? Wed, 21 Mar 2012 00:00:00 -0500 http://www.contractpharma.com/contents/view_experts-opinion/2012-03-21/ma-in-big-pharma/ http://www.contractpharma.com/contents/view_experts-opinion/2012-02-29/fda-issues-draft-guidances-on-biosimilars/ An initial take on the Agency's proposal for biosimilars Wed, 29 Feb 2012 00:00:00 -0500 http://www.contractpharma.com/contents/view_experts-opinion/2012-02-29/fda-issues-draft-guidances-on-biosimilars/ http://www.contractpharma.com/contents/view_experts-opinion/2012-02-08/a-500-million-blunder/ Was the departure of Lonza's CEO too hasty? Wed, 08 Feb 2012 00:00:00 -0500 http://www.contractpharma.com/contents/view_experts-opinion/2012-02-08/a-500-million-blunder/ http://www.contractpharma.com/contents/view_experts-opinion/2011-12-14/ppd-goes-private-whats-next/ Acquired by PE firms, the CRO looks to the future Wed, 14 Dec 2011 00:00:00 -0500 http://www.contractpharma.com/contents/view_experts-opinion/2011-12-14/ppd-goes-private-whats-next/ http://www.contractpharma.com/contents/view_experts-opinion/2011-12-06/bio-outsourcing-budgets-up-slightly/ Sponsors funding more, different projects Tue, 06 Dec 2011 00:00:00 -0500 http://www.contractpharma.com/contents/view_experts-opinion/2011-12-06/bio-outsourcing-budgets-up-slightly/ http://www.contractpharma.com/contents/view_experts-opinion/2011-10-05/why-bis-biosimilar-announcement-just-makes-sense/ Unique skillsets and assets explain why BI is primed for success in this burgeoning market Wed, 05 Oct 2011 00:00:00 -0500 http://www.contractpharma.com/contents/view_experts-opinion/2011-10-05/why-bis-biosimilar-announcement-just-makes-sense/ http://www.contractpharma.com/contents/view_experts-opinion/2011-09-19/when-the-unexpected-happens/ High Labor Cost Countries are making a comeback against low-cost counterparts Mon, 19 Sep 2011 00:00:00 -0500 http://www.contractpharma.com/contents/view_experts-opinion/2011-09-19/when-the-unexpected-happens/ http://www.contractpharma.com/issues/2011-09/view_experts-opinion/the-shape-of-the-post-bvmarket/ The broader implications of Ben Venue exiting the CMO space Wed, 07 Sep 2011 00:00:00 -0500 http://www.contractpharma.com/issues/2011-09/view_experts-opinion/the-shape-of-the-post-bvmarket/ http://www.contractpharma.com/contents/view_experts-opinion/2011-06-22/bio-preview-the-biopharma-outsourcing-advantage/ Industry trends create opportunities for bio-CMOs and CROs Wed, 22 Jun 2011 00:00:00 -0500 http://www.contractpharma.com/contents/view_experts-opinion/2011-06-22/bio-preview-the-biopharma-outsourcing-advantage/ http://www.contractpharma.com/contents/view_experts-opinion/2011-06-09/dosage-delivery-for-oral-liquid-otcs/ A new FDA guidance is set to prompt manufacturers into action Thu, 09 Jun 2011 00:00:00 -0500 http://www.contractpharma.com/contents/view_experts-opinion/2011-06-09/dosage-delivery-for-oral-liquid-otcs/ http://www.contractpharma.com/contents/view_experts-opinion/2011-06-01/china-vs-india-in-the-api-race-/ Wed, 01 Jun 2011 00:00:00 -0500 http://www.contractpharma.com/contents/view_experts-opinion/2011-06-01/china-vs-india-in-the-api-race-/